Welcome to our dedicated page for Gaxos.AI SEC filings (Ticker: GXAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Gaxos.ai Inc. (GXAI) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. As a Nasdaq Capital Market issuer and an emerging growth company, Gaxos submits reports and proxy materials that describe its governance, shareholder votes, equity plans, and other material events.
Key filings for Gaxos.ai include Form 10-K annual reports and Form 10-Q quarterly reports, which present audited and interim financial statements, risk factors, and management’s discussion of operations. Investors can use these documents to understand how the company’s AI platforms, subscription models, and sector focus are reflected in its financial reporting and disclosures.
Current reports on Form 8-K capture significant events such as the results of annual meetings, changes in corporate structure, or other material developments. For example, Gaxos has filed an 8-K describing the outcomes of shareholder votes on director elections, ratification of its independent registered public accounting firm, and amendments to its 2022 Omnibus Equity Incentive Plan.
The company’s proxy statements (DEF 14A) provide detail on board composition, executive and director compensation, equity incentive plans, and the specific proposals presented to shareholders at the annual meeting. These documents also outline the procedures for voting, record dates, and meeting logistics.
On Stock Titan, Gaxos.ai filings are updated in near real time as they appear on EDGAR. AI-powered summaries help explain long and complex filings by highlighting key topics such as equity plan changes, auditor ratification, and governance matters, allowing users to quickly identify the sections most relevant to their analysis.
GAXOS.AI Inc. director Grayson Scott received an option grant for 25,000 shares of Common Stock at an exercise price of $1.32 per share. The options were granted at no cost, vesting 100% on the one-year anniversary of the March 20, 2026 grant date and expiring on March 20, 2031. Following this grant, Scott holds options covering 53,750 shares directly.
GAXOS.AI INC. director Roman Feldman received an employee stock option grant covering 25,000 shares of common stock. The options have an exercise price of $1.3200 per share and were awarded at no cost as a compensation grant.
According to the terms, 100% of the shares underlying the option vest on the one-year anniversary of the March 20, 2026 grant date. Following this award, Feldman holds options to acquire a total of 50,000 shares of GAXOS.AI common stock directly.
GAXOS.AI INC. director Adam Holzer received an award of 25,000 employee stock options to buy common stock at an exercise price of $1.32 per share. The options were granted under the 2022 Equity Incentive Plan and vest 100% on the one-year anniversary of the grant date. Following this grant, Holzer holds 53,750 stock options in total.
Gaxos.ai Inc. disclosed that it has increased the maximum aggregate offering price of common stock that may be issued under its at-the-market offering agreement with H.C. Wainwright & Co. by an additional $1,065,001. This at-the-market program allows the company to issue and sell shares of its common stock from time to time through the sales agent.
The company notes that this new capacity is in addition to approximately $5,600,000 of common stock already sold under the same agreement. Gaxos.ai also filed a prospectus supplement and included a legal opinion from Sheppard Mullin Richter & Hampton LLP covering the validity of the shares issued under the updated program.
Gaxos.ai Inc. is supplementing its prior prospectuses to raise the size of its at-the-market program under the Sales Agreement with H.C. Wainwright & Co. The company is offering up to an additional $1,065,001 of its common stock pursuant to the Sales Agreement.
The supplement states the Sales Agreement previously produced gross proceeds of approximately $5,600,000 from 3,096,481 shares sold. It reports 10,219,934 shares outstanding and 9,997,502 shares held by non-affiliates as of the prospectus supplement, with a disclosed public float market value of $19,995,004 using a $2.00 per-share price on February 3, 2026. The Company notes compliance with General Instruction I.B.6 of Form S-3.
Gaxos.AI Inc. reports on its evolving AI-focused business, highlighting multiple new products and substantial risk factors. The company is building a portfolio across gaming, health, wellness, faith and creative tools, including Gaxos Labs, Gaxos Gaming, Gaxos Health and RNK Health.
Recent launches include a generative AI service for game assets, UnGPT.ai for humanizing AI text, Art-Gen.AI for image and video creation, and Bible Pray AI for digital faith and wellness. Gaxos Health introduced an AI-powered health optimization product and RNK Health now operates as a 70%-owned subsidiary.
The filing notes an early-stage profile with limited operating history, no sustainable revenue and expectations of continued losses, requiring additional financing. As of December 31, 2025, cash was $840,499, short-term investments $11,345,187 and working capital $11,919,230, with $3,853,757 of net cash used in operations in 2025.
In January 2026, Gaxos.AI entered an at-the-market equity program of up to $5,600,000, and in March 2026 purchased 19.99% of America First Defense.AI LLC for $2,900,000. The report emphasizes extensive risks around AI use, data privacy, cybersecurity, healthcare regulation, intense competition and potential stock price volatility, including Nasdaq delisting risk.
Gaxos.ai Inc. entered into a Membership Interest Purchase Agreement to acquire 19.99% of America First Defense.AI LLC for an aggregate cash purchase price of $2,900,000. Closing is expected on or before March 5, 2026, subject to the agreement's conditions.
The membership interests are being sold in a private transaction relying on Section 4(a)(2) of the Securities Act and are subject to transfer restrictions and tag-along rights for Gaxos in certain future AFD sales. Gaxos highlights this stake as a strategic move into advanced drone-based electronic warfare and soft-robotics defense technologies.
Gaxos.ai Inc. expanded its existing at-the-market stock offering program with H.C. Wainwright & Co. by authorizing up to an additional $2,600,000 of common stock sales. This increase is on top of approximately $3,000,000 of common stock already sold under the same agreement.
The company also filed a new prospectus supplement covering these additional shares and provided a legal opinion from Sheppard Mullin Richter & Hampton LLP confirming the validity of the common stock to be issued.
Gaxos.ai Inc. is offering up to an additional $2,600,000 of common stock under its at-the-market Sales Agreement with H.C. Wainwright & Co.
The company previously sold 1,515,700 shares for gross proceeds of approximately $3,000,000 under this agreement. As of February 3, 2026, it had 8,639,153 shares outstanding and a public float of 8,416,721 shares valued at about $16,833,442 at $2.00 per share. Under Form S-3 General Instruction I.B.6, it may offer shares with an aggregate offering price of up to approximately $2,611,395.
Gaxos.ai Inc. has established an at-the-market offering program to sell up to $3,000,000 of common stock through H.C. Wainwright & Co. as sales agent. The shares may be sold from time to time on Nasdaq or other permitted markets, with Gaxos.ai paying Wainwright a 3.0% sales commission.
As of January 20, 2026, Gaxos.ai had 7,123,453 shares of common stock outstanding and estimates that, assuming sales at $1.09 per share, this program could add about 2,752,293 shares, bringing total shares up to 9,875,746. The company’s net tangible book value was $1.83 per share as of September 30, 2025 and would be $1.61 per share on a pro forma basis after the assumed full ATM usage, meaning existing holders see a book value decrease while new investors buy at a discount to that adjusted value.
The company plans to use any net proceeds for general corporate purposes, including capital expenditures, working capital and general and administrative expenses. The filing highlights that the stock is volatile, that investors may experience dilution and differing purchase prices over time, and that Gaxos.ai is an emerging growth and smaller reporting company using scaled disclosure and extended accounting transition periods.